News

LexinFintech Holdings Reports Solid Q4 and Full Year Financials

LexinFintech Holdings Reports Solid Q4 and Full Year Financials

LexinFintech Holdings Q4 2024 Financial Results Overview

LexinFintech Holdings Ltd. (NASDAQ: LX), known as a technology-driven personal finance service provider, has added a new chapter to its success story by reporting its unaudited financial results for the fourth quarter of 2024. The company has showcased its robust growth and strategic adjustments to adapt to the shifting economic landscape.

Quarterly Performance Highlights

In the fourth quarter, Lexin achieved a net income of RMB363 million, marking a substantial increase of about 17% from the previous quarter. This achievement demonstrates Lexin's consistent profitability, a trend that has extended over four consecutive quarters. Concurrently, the company's total loan origination stood at RMB52 billion, reflecting a modest 2% quarter-over-quarter growth.

Revenue and Profitability Growth

The company’s revenue for the quarter reached RMB3,659 million, showing an increase of 4.3% year-over-year. A particularly noteworthy point is the strong performance of its tech-empowerment services, which surged by 41% compared to the previous year, contributing RMB602 million to the total revenue.

Lexin's net income per American Depository Share (ADS) rose to RMB2.06 on a fully diluted basis, which is a remarkable recovery and positions the company favorably for the upcoming fiscal periods.

Asset Quality and Operational Improvements

Lexin has been prioritizing risk management and enhancing asset quality. The results indicate that their efforts are paying off, as risk indicators for newly originated loans have declined. With an outstanding loan balance of RMB110 billion, Lexin is managing its assets effectively, maintaining sustainable growth amidst the competitive landscape.

Looking forward to 2025, Lexin plans to uphold its focus on profitability enhancement while ensuring asset quality remains a priority. In this way, the company aims to safeguard its steady performance growth despite potential economic challenges.

Future Outlook and Dividend Declaration

As part of its semi-annual dividend strategy, Lexin's board has approved a dividend of US$0.11 per ADS, representing about 20% of its net income from the latter half of 2024. From January 1, 2025, this payout ratio is expected to increase to 25%, reinforcing their commitment to returning value to shareholders.

User Base Growth

The user engagement numbers further highlight Lexin's success. The total number of registered users grew to 228 million by the end of 2024, reflecting an 8.6% increase from the previous year. Moreover, the number of active users utilizing loan products for the quarter was recorded at 4.7 million. While there was a slight decline in the overall active user base for the year, the growth of cumulative borrowers shows a healthy long-term trend.

Operational Metrics and Innovations

In terms of loan facilitation, Lexin has cumulatively originated RMB1,325.1 billion in loans, an impressive 19.1% increase from 2023. However, the total loan originations for the quarter reflected a decrease of 15.2% year-over-year. The company attributes this to a more cautious approach in a changing economic environment.

As the demand for innovative financial services grows, Lexin continues to leverage cutting-edge technology to boost customer acquisition efficiency and improve product offerings. Their tech-empowering services cater to over 100 business clients, solidifying their position as a leading fintech player.

Conference Call and Investor Relations

Lexin’s management will host an earnings conference call, allowing investors to dive deeper into the financial results and outlook. These efforts reflect the company's commitment to transparency and shareholder communication.

Frequently Asked Questions

What are the key highlights from Lexin's Q4 2024 results?

Lexin reported a net income of RMB363 million, a 17% increase from Q3, along with total revenue of RMB3,659 million, reflecting solid performance and operational improvements.

How has Lexin's user base changed recently?

The total registered user base grew to 228 million, marking an 8.6% increase compared to the previous year.

What is Lexin's outlook for 2025?

Lexin expects flat to single-digit growth in total loan origination and a significant increase in net income driven by margin expansion and risk management.

What is the company’s dividend policy?

The board has approved a dividend of US$0.11 per ADS and plans to increase the payout ratio to 25% from January 1, 2025.

How has Lexin's loan origination performance varied?

While cumulative loan originations increased, the quarterly loan origination decreased by 15.2%, as the company adopted a more cautious approach to manage risk in the current economic climate.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Horowitz's $150M Boost for Nevada's First Children's Hospital

Updated Category News Views 97

Big Bucks and Bigger Hearts Boost Pediatric Care in Nevada The world isn't exactly short on folks looking to make a buck, but every so often, someone comes along and wants to make a difference instead. Enter Felicia and Ben Horowitz, handing over a staggering $150 million to Intermountain Health. This isn’t your garden-variety gift—it’s aimed at getting Nevada on...

Continue Reading
UCB's Endowment Marks New Era in Medicine Evaluation

Updated Category News Views 60

Stepping into a New Chapter for Medicine Evaluation UCB's latest move smacks of a strategic vision that's not just about immediate returns—it's a long game in pharmacoepidemiology. You don't see investors lining up for this news, but this chair at Brigham and Women's is bigger than it looks. By establishing the Emmanuel Janssen Endowed Chair, UCB is underpinning the...

Continue Reading
Steady Income Boosts FHLBank Boston's Growth Q3 2026

Updated Category News Views 50

The Federal Home Loan Bank of Boston dropped their third-quarter results for 2026 like a hot smokestack, and let me tell you, it's a mixed bag of cautious optimism and steady progression. It's essentially proof that slow and steady might just win the race—or at least keep you in the running. Stable and Steady Headway Taking a peek under the hood, FHLBank Boston made a...

Continue Reading
Wisconsin Brats Clash with Florida Citrus in Marketing Showdown

Updated Category News Views 14

A Juicy Rivalry with Sweet and Savory Stakes You ever catch yourself watching state pride turn into a marketing showdown? That's what's cookin' with Wisconsin's Johnsonville and Florida's Natural, and believe me, this isn't just about what’s on your plate. Forget the foam fingers, here it's all about the brats and the OJ. It's like the Packers versus the Dolphins, but...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 28

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
Patrick Ta Beauty Adds New Leadership to Expand Growth

Updated Category News Views 36

Angela Simpson and Carolyne Rapp Join the Ranks In the fast-paced world of beauty, where trends shift faster than a day trader’s mood, Patrick Ta Beauty is shaking things up with some heavyweight hires. Angela Simpson steps in as Chief Marketing Officer, and Carolyne Rapp takes the reins as Vice President of Creative. Maybe it’s just me, but when a brand ropes in pros...

Continue Reading
Lunit, Summit Tackle Tumor Analysis with AI Platform

Updated Category News Views 168

Amid whispers of AI revolutionizing every industry, let's zero in on its latest pit stop—oncology R&D. Lunit, shaking hands with Summit Therapeutics, plans to bring artificial intelligence into the tumor microenvironment analysis game, thanks to the Lunit SCOPE IO platform. This isn't just another lab experiment; it's a step towards redefining how we understand cancer's...

Continue Reading
Hyperliquid Reports Q3 2026 Results with Webcast Insights

Updated Category News Views 74

Unlocking Hyperliquid’s Third Quarter Performance It's time to grab your investing gear because Hyperliquid Strategies Inc is ready to spill the beans on their Q3 2026 performance. The digital asset treasury focused on the hyperventilating HYPE token—fined-tuned to serve US and institutional investors—is broadcasting a live webcast on November 5, 2026. Mark your...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 57

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
Veterans Find Community and Wellness at Orland Hills Bash

Updated Category News Views 16

A Celebration of Veterans and Community Orland Hills is set to light up with a unique Veterans Day Bash on November 1, 2026. This isn't just your run-of-the-mill community gathering; it's an event that brings together veterans from all around for a day packed with resources, education, and a chance to connect with kindred spirits—all thanks to the collaboration between...

Continue Reading

Top 5 Most Recently Viewed Articles

2026 Best Buddies Challenge Hits $4M For Inclusion

Updated Category News Views 7

A Record-Breaking Year for Best Buddies Everyone loves a good underdog story, and every now and then, you get one that really hits home. The 27th Annual Best Buddies Challenge in Hyannis Port did exactly that, raking in a whopping $4 million and drawing a crowd of nearly 1,000 participants. The event serves as both a fundraiser and a community builder, spotlighting its...

Continue Reading
MSP Recovery Implements Reverse Stock Split for Compliance

Updated Category News Views 239

MSP Recovery Announces a Reverse Stock Split MSP Recovery, Inc. (NASDAQ: MSPR), a leader in Medicare, Medicaid, and secondary payer reimbursement recovery, recently announced a reverse stock split of its Class A common stock at a ratio of 1-for-7. This strategic move aims to ensure compliance with Nasdaq's minimum bid price requirement. Details of the Stock Split The...

Continue Reading
The Value of a $1000 Investment in Primerica Over 10 Years

Updated Category News Views 127

Understanding Primerica's Growth Over the Last Decade Primerica Inc (NYSE: PRI) has shown remarkable performance, outperforming the market by an annualized rate of 8.02%. This impressive rate results in an average annual return of 19.51% for the investors over the past ten years. As of now, the company has a market valuation of approximately $8.63 billion, indicating...

Continue Reading
Innovative G-Rex Grants Propel Cell Therapy Manufacturing Growth

Updated Category News Views 161

Innovative G-Rex Grants Propel Cell Therapy Manufacturing Growth ScaleReady, in partnership with Wilson Wolf Manufacturing and Bio-Techne Corporation (NASDAQ: TECH), has announced an exciting initiative aimed at enhancing cell and gene therapy manufacturing. Eight G-Rex Grants, amounting to nearly $2 million, have been awarded to distinguished recipients within the...

Continue Reading